The aim of the present study is to assess whether the application of a new hydrocellular polyurethane foam multilayer dressing shaped for the sacral area (MSP) in addition to standard care reduces the rate of pressure sores (PU) and their severity especially in the elderly population admitted for fragility Hip Fractures.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
359
Application of hydrocellular polyurethane foam in the sacral region within 24 hours of admission and replaced when detaches or gets wet or dirty in addition to standard care
Standard care: PU risk assessment using the Braden scale within 24 hours of admission. Place patient on pressure mattress (static or alternating pressure) if Braden score \<18, daily inspection of the skin in the various pressure points and moving the patient every 4 hours after surgery. Management of possible incontinence, humidity control and prevention of skin damage and rubbing/friction during postural changes as per hospital procedure.
Istituto Ortopedico Rizzoli
Bologna, Italy
Number of Participants With Pressure Sores
Time frame: On the eighth day of hospitalization or upon discharge from hospital, if that occurs before the eighth day.
Number of Participants With Pressure Ulcers in Other Areas (Heel, Back and Calf)
Time frame: On the eighth day of hospitalization or upon discharge from hospital, if that occurs before the eighth day.
Pressure Ulcer Rate in the Sacral Area of Grade ≥ II According to the National Pressure Ulcers Advisory Panel Classification
Pressure ulcer are classified and described through the use of staging systems. Staging systems describe the extent of tissue loss and the physical appearance of the injury caused by pressure and/or shear. From stage 1 (intact skin) to Stage 4 (Full-thickness skin and tissue loss).
Time frame: On the eighth day of hospitalization or upon discharge from hospital, if that occurs before the eighth day.
Number of Participants With Skin Irritation/Damage Due to the Adhesive Dressing
Clinical evaluation. It refers to any sort of inflammation and/or discoloration that distorts the skin's normal appearance. The skin may become scaly, bumpy, itchy, or otherwise irritated.
Time frame: On the eighth day of hospitalization or upon discharge from hospital, if that occurs before the eighth day.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.